Tiliroside targets TBK1 to induce ferroptosis and sensitize hepatocellular carcinoma to sorafenib
Chen Yang, Tao Lu, Ming Liu, Xiaoqing Yuan, Desheng Li, Jiayu Zhang, Ling Zhou, Maolei Xu
Topics & Concepts
SorafenibIn vivoChemistryHepatocellular carcinomaIn vitroGene knockdownCancer researchPharmacologyBiochemistryApoptosisBiologyBiotechnologyFerroptosis and cancer prognosisCancer, Lipids, and MetabolismCancer Mechanisms and Therapy